Cas 312263-45-9,L-Alanine, N-[(4-iodophenyl)sulfonyl]-3-[[4-[2-(1,5,6,7-tetrahydro-1,8-naphthyridin-2 -yl)ethyl]benzoyl]amino]-

312263-45-9

Post Buying Request

Basic information

Product Name: L-Alanine, N-[(4-iodophenyl)sulfonyl]-3-[[4-[2-(1,5,6,7-tetrahydro-1,8-naphthyridin-2 -yl)ethyl]benzoyl]amino]-
Synonyms:
CAS NO:312263-45-9
Molecular Formula: C26H27IN4O5S
Molecular Weight: 634.495
EINECS: N/A
Product Categories: N/A
Mol File: 312263-45-9.mol

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: L-Alanine, N-[(4-iodophenyl)sulfonyl]-3-[[4-[2-(1,5,6,7-tetrahydro-1,8-naphthyridin-2 -yl)ethyl]benzoyl]amino]-(CAS DataBase Reference)
NIST Chemistry Reference: L-Alanine, N-[(4-iodophenyl)sulfonyl]-3-[[4-[2-(1,5,6,7-tetrahydro-1,8-naphthyridin-2 -yl)ethyl]benzoyl]amino]-(312263-45-9)
EPA Substance Registry System: L-Alanine, N-[(4-iodophenyl)sulfonyl]-3-[[4-[2-(1,5,6,7-tetrahydro-1,8-naphthyridin-2 -yl)ethyl]benzoyl]amino]-(312263-45-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 312263-45-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

312263-45-9 Suppliers

Recommended suppliers

312263-45-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 312263-45-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,1,2,2,6 and 3 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 312263-45:
(8*3)+(7*1)+(6*2)+(5*2)+(4*6)+(3*3)+(2*4)+(1*5)=99
99 % 10 = 9
So 312263-45-9 is a valid CAS Registry Number.

312263-45-9Upstream product

312263-44-8 2(S)-(4-iodo-benzenesulfonylamino)-3-{4-[2-(5,6,7,8-tetrahydro-[1,8]naphthyridin-2-yl)-ethyl]-benzoylamino}-propionic acid ethyl ester

312263-45-9Downstream Products

312263-46-0 3-{4-[2-(5,6,7,8-tetrahydro-[1,8]naphthyridin-2-yl)-ethyl]-benzoylamino}-2(S)-(4-trimethylstannyl-benzenesulfonylamino)-propionic acid

312263-45-9Relevant academic research and scientific papers

Alpha v integrin receptor antagonists

-

, (2008/06/13)

The present invention relates to novel chain-fluorinated alkanoic acid derivatives thereof, their synthesis, and their use as αv integrin receptor antagonists. More particularly, the compounds of the present invention are antagonists of the integrin recep

Dibenzoxazepine alpha v integrin receptor antagonist

-

Page/Page column 11-12, (2010/02/05)

The present invention relates to a novel dibenzoxazepine derivative, its synthesis, and its use as an αv integrin receptor antagonist. More particularly, the compound of the present invention is an antagonist of the integrin receptors αvβ3 and αvβ5 and th

αv integrin receptor antagonists

-

, (2008/06/13)

The present invention relates to novel nonanoic acid derivatives, their synthesis, and their use as αv integrin receptor antagonists. More particularly, the compounds of the present invention are antagonists of the integrin receptors αvβ3 and αvβ5 and are

Alpha V integrin receptor antagonists

-

, (2008/06/13)

The present invention relates to novel imidazolidinone derivatives thereof, their synthesis, and their use as αv integrin receptor antagonists. More particularly, the compounds of the present invention are antagonists of the integrin receptors αvβ3 and/or

Integrin receptor antagonists

-

, (2008/06/13)

The present invention relates to compounds and derivatives thereof, their synthesis, and their use as vitronectin receptor antagonists. More particularly, the compounds of the present invention are antagonists of the integrin receptors αvβ3 and/or αvβ5 an

Alpha V integrin receptor antagonists

-

, (2008/06/13)

The present invention relates to novel alkanoic acid derivatives thereof, their synthesis, and their use as αv integrin receptor antagonists. More particularly, the compounds of the present invention are antagonists of the integrin receptors αvβ3 and/or α

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 312263-45-9